| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2051680 | B | Inhibition of norA-mediated EtBr efflux in Staphylococcus aureus SA1199B overexpressing norA and expressing A116E GrlA mutation at 50 uM by fluorometry | Staphylococcus aureus | 9 | single protein format | Scientific Literature | ||
| 2. | ALA2051681 | B | Inhibition of norA-mediated EtBr efflux in Staphylococcus aureus SA1199B overexpressing norA and expressing A116E GrlA mutation by fluorometry | Staphylococcus aureus | 2 | single protein format | Scientific Literature | ||
| 3. | ALA2051686 | B | Inhibition of norA in wild type Staphylococcus aureus SA1199 expressing assessed as potentiation of ciprofloxacin MIC by checkerboard assay | Staphylococcus aureus | 4 | single protein format | Scientific Literature | ||
| 4. | ALA2051687 | B | Inhibition of norA overexpressed in Staphylococcus aureus SA1199B coexpressing A116E GrlA mutation assessed as potentiation of ciprofloxacin MIC by checkerboard assay | Staphylococcus aureus | 4 | assay format | Scientific Literature | ||
| 5. | ALA2051688 | B | Inhibition of norA in Staphylococcus aureus SA1199B overexpressing norA and expressing A116E GrlA mutation assessed as fold reduction in ciprofloxacin MIC at >6.25 ug/mL by checkerboard assay | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 6. | ALA2051689 | B | Inhibition of norA overexpressed in Staphylococcus aureus SA1199B coexpressing A116E GrlA mutation assessed as fold reduction in ciprofloxacin MIC at >12.5 ug/mL by checkerboard assay | Staphylococcus aureus | 1 | assay format | Scientific Literature | ||
| 7. | ALA2051690 | B | Inhibition of norA overexpressed in Staphylococcus aureus SA1199B coexpressing A116E GrlA mutation potentiation of EtBr MIC at >6.25 ug/mL by checkerboard assay | Staphylococcus aureus | 1 | assay format | Scientific Literature | ||
| 8. | ALA2051692 | B | Inhibition of norA overexpressed in Staphylococcus aureus SAK2378 assessed as potentiation of CPX MIC by checkerboard assay | Staphylococcus aureus | 1 | assay format | Scientific Literature | ||
| 9. | ALA2049765 | B | Inhibition of norA-mediated ethidium bromide efflux in Staphylococcus aureus SA-1199B harboring grlA A116E mutant at 50 uM after 5 mins by fluorometric analysis | Staphylococcus aureus | 11 | single protein format | Scientific Literature | ||
| 10. | ALA1817147 | B | Inhibition of NorA in Staphylococcus aureus 1199B assessed as inhibition of ethidium bromide efflux at 50 uM by fluorimetry | Staphylococcus aureus | 26 | single protein format | Scientific Literature | ||
| 11. | ALA1817268 | B | Inhibition of NorA in Staphylococcus aureus 1199B norA++ and A116E GrlA mutation assessed as reduction in ciprofloxacin MIC at 25 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 12. | ALA1817269 | B | Inhibition of NorA in Staphylococcus aureus 1199B norA++ and A116E GrlA mutation assessed as reduction in ciprofloxacin MIC at 100 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 13. | ALA1817270 | B | Inhibition of NorA in Staphylococcus aureus 1199B norA++ and A116E GrlA mutation assessed as reduction in ciprofloxacin MIC at 50 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 14. | ALA1817271 | B | Inhibition of NorA in Staphylococcus aureus K2378 bearing norA++ efficient mutation assessed as reduction in ciprofloxacin MIC at 1.56 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 15. | ALA1817272 | B | Inhibition of NorA in Staphylococcus aureus K2378 bearing norA++ efficient mutation assessed as reduction in ciprofloxacin MIC at 12.5 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 16. | ALA1817273 | B | Inhibition of NorA in Staphylococcus aureus K2378 bearing norA++ efficient mutation assessed as reduction in ciprofloxacin MIC at 3.13 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 17. | ALA1817274 | B | Inhibition of NorA in Staphylococcus aureus K2378 bearing norA++ efficient mutation assessed as reduction in ciprofloxacin MIC at 6.25 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 18. | ALA1817275 | B | Inhibition of wild-type norA expressing Staphylococcus aureus 1199 assessed as reduction in ciprofloxacin MIC | Staphylococcus aureus | 6 | single protein format | Scientific Literature | ||
| 19. | ALA1817276 | B | Inhibition of NorA in Staphylococcus aureus 1199B norA++ and A116E GrlA mutation assessed as reduction in ciprofloxacin MIC at >12.5 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature | ||
| 20. | ALA1817277 | B | Inhibition of NorA in Staphylococcus aureus 1199B norA++ and A116E GrlA mutation assessed as reduction in ciprofloxacin MIC at >=12.5 ug/mL | Staphylococcus aureus | 1 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!